Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Renewal of Intestinal Stem Cells

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Piezoelectric materials for tissue engineering and regenerative medicine: From fundamental principles to clinical applications.

Acta biomaterialia·2026

Same author

Retraction of "3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo".

Biomacromolecules·2026

Same author

Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.

Biomaterials advances·2025

Same author

Correction: Aleemardani et al. Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury. <i>Biomedicines</i> 2022, <i>10</i>, 73.

Biomedicines·2025

Same author

Bilateral Crosslinking with Glutaraldehyde and 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide: An Optimization Strategy for the Application of Decellularized Human Amniotic Membrane in Tissue Engineering.

Journal of tissue engineering and regenerative medicine·2025

Same author

Correction to "3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo".

Biomacromolecules·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Tissue Engineering of the Intestine in a Murine Model

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

Tissue engineering of small intestine--current status.

Ashish Gupta¹, Anupam Dixit, Kevin M Sales

¹Biomaterials and Tissue Engineering Centre, Academic Division of Surgery and Interventional Sciences, University College London, London NW3 2PF, United Kingdom.

Biomacromolecules

|October 10, 2006

Summary

Tissue engineering offers a promising alternative for short bowel syndrome (SBS). Researchers are developing artificial intestines using stem cells and biodegradable materials to increase intestinal surface area for patients with intestinal failure.

More Related Videos

A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix

A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix

Published on: October 7, 2013

Small Bowel Transplantation In Mice

Small Bowel Transplantation In Mice

Published on: August 20, 2007

Related Experiment Videos

Last Updated: Jul 19, 2026

Tissue Engineering of the Intestine in a Murine Model

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix

A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix

Published on: October 7, 2013

Small Bowel Transplantation In Mice

Small Bowel Transplantation In Mice

Published on: August 20, 2007

Area of Science:

Biomedical Engineering
Regenerative Medicine
Gastroenterology

Background:

Short bowel syndrome (SBS) presents significant morbidity and mortality, with current treatments like parenteral nutrition (PN) and transplantation having limitations.
PN is associated with sepsis and liver failure, while transplantation faces donor organ scarcity and graft rejection issues.
Existing therapeutic options for SBS are not permanent solutions, highlighting the need for alternative treatments.

Purpose of the Study:

To review the current progress in small intestinal tissue engineering.
To explore potential cell sources and scaffold materials for artificial intestine development.
To discuss the promise of tissue-engineered intestines as a novel therapy for SBS.

Main Methods:

Review of existing literature on small intestinal tissue engineering techniques.
Analysis of studies involving seeding of intestinal epithelial organoids onto biodegradable polymers.
Examination of advancements in cultured stem cell and polymer technologies.

Main Results:

Successful generation of intestinal neomucosa in animal models using seeded organoid units on biodegradable polymers.
Demonstration of potential for engineered intestinal tissue to increase absorptive surface area.
Identification of cultured stem cells and advanced polymer technology as key components for future development.

Conclusions:

Small intestinal tissue engineering holds significant promise for developing an 'off-the-shelf' artificial intestine.
Continued research in cell sources and scaffold materials is crucial for advancing this novel therapy.
Tissue-engineered intestines could offer a viable, potentially permanent solution for patients suffering from intestinal failure due to SBS.